Homepage

Ebola vaccine approved for use by the European Commission

The European Commission has granted Marketing Authorisation to Janssen for a new Ebola vaccine, developed in partnership with the University of Oxford.

Trial of Oxford COVID-19 vaccine starts in Brazil

Volunteers have begun taking part in Latin America’s first clinical trial for a vaccine against COVID-19.

The Duke of Cambridge visits Oxford Vaccine Centre

The Duke of Cambridge visits the University of Oxford’s Oxford Vaccine Centre, to learn more about their work to establish a viable vaccine against COVID-19.

Trial of Oxford COVID-19 vaccine in South Africa begins

Participants in South Africa’s first clinical trial for a vaccine against COVID-19 are to be vaccinated this week.

Dr Samantha Vanderslott and Dr Claas Kirchelle with elm-encased lead pipes that crossed over the Thames.

Alice in Typhoidland wins film trophy

Bristol Science Film Festival awarded the Professional Science Fact Film Prize to "The Adventures of Alice in Typhoidland" co-created by the Oxford Vaccine Group.

Oxford COVID-19 vaccine to begin phase II/III human trials

Oxford Vaccine Group researchers have begun recruiting for the next phase in human trials of a COVID-19 vaccine in human volunteers.

Funding for new COVID-19 studies awarded to OVG's project on infectious disease immunity in children

Five projects from across Oxford University's Medical Sciences Division, including a project led by Professor Matthew Snape from the Oxford Vaccine Group, are among twenty-one new studies into the novel coronavirus which have been funded by the UK government.

Is mandatory vaccination the best way to tackle falling rates of childhood immunisation?

Following the publication of figures showing UK childhood vaccination rates have fallen for the fifth year in a row, researchers from OVG and the Oxford Martin Programme on Collective Responsibility for Infectious Disease discuss possible responses.

Take part in a clinical trial – see a list of all the trials we are currently recruiting to.

Vaccine Knowledge

The Vaccine Knowledge Project aims to be a source of independent information about vaccines and infectious diseases.

See more

Research

Vaccines are a key component of global health policy and are essential in the defence of the health of young children. Our research focuses on the development and evaluation of new and improved vaccines.

Explore

Events and Training

We are committed to providing high quality education and training, together with research updates for medical professionals and all those involved in the area of vaccines and paediatric and adult infectious diseases.

Learn

Get involved

There are a number of ways in which you can get involved in our research, inform our research and find out more about our work. To find out more about any of these options, follow the link below.

Participate

Upcoming events

Virtual Influenza Vaccination Update Training - 3 August 2020

Monday, 03 August 2020, 10am to 12.30pm

This training is for general practice nurses and other health professionals who as part of their role already administer and promote / advise about influenza vaccines. The training will cover the theory of the influenza programme.** Please note the local logistics of delivering the 2020/21 influenza programme will NOT be addressed **

Virtual Influenza Vaccination Update Training - 4 August 2020

Tuesday, 04 August 2020, 10am to 12.30pm

17th OVG Immunisation Seminar

Thursday, 22 October 2020 @ Kassam Stadium Conference Centre, Grenoble Road, Oxford, OX4 4XP

The annual Immunisation Seminar will be held at the Kassam Stadium Conference Centre, Oxford. It provides the ideal opportunity for practitioners to update their current immunisation knowledge and to hear the latest news on the topic of vaccination.

Latest publications

Health diplomacy across borders: the case of yellow fever and COVID-19
Journal article

Vanderslott S. and Marks T., (2020), Journal of Travel Medicine
Neglected Tropical Diseases
Journal article

Vanderslott S., (2020), Nature and Culture, 15, 78 - 110
Herd Immunity and Vaccination of children for COVID19.
Journal article

Velavan TP. et al, (2020), Int J Infect Dis
Evaluation of a standardised Vi poly-l-lysine ELISA for serology of Vi capsular polysaccharide antibodies.
Journal article

Rigsby P. et al, (2020), Biologicals
Antibody testing for COVID-19: A report from the National COVID Scientific Advisory Panel
Journal article

Adams ER. et al, (2020), Wellcome Open Research, 5, 139 - 139

How does herd immunity work?

‘Herd immunity’ or 'herd protection' gives protection to vulnerable people such as newborn babies, elderly people and those who are too sick to be vaccinated.

Value of Vaccines campaign

We recently worked with Mediaplanet on the 2019 Health Awareness: Value of Vaccines campaign. The campaign features exclusive content from key thought leaders and industry voices about the critical importance of full immunisation throughout life.

Take a look!